LOCAL listed pharmaceutical company Biopharmica has announced successful results from work conducted by the Western Australian Institute for Medical Research (WAIMR) on a cancer gene.
BioPharmica Limited - July 2Proposed code: BPHIssue price: $0.20Principal activities: Biomedical commercialisation business partnering univerisities, medical institutes, companies and hospitals.Corpor
BioPharmica Limited - July 2Proposed code: BPHIssue price: $0.20Principal activities: Biomedical commercialisation business partnering univerisities, medical institutes, companies and hospitals.Corpor
BioPharmica Limited - July 2Proposed code: BPHIssue price: $0.20Principal activities: Biomedical commercialisation business partnering universities, medical institutes, companies and hospitals.Corpora
LOCAL biomedical company BioPharmica intends to list on the Australian Stock Exchange and will go to the market in the coming weeks, aiming to raise $4.5 million.
20 Apr 2004
Subscribe today for award-winning, unbiased and trusted journalism
